Age is the greatest risk factor for Alzheimer's disease. Key pathways within the biology of aging may represent important targets to develop novel and effective disease-modifying drugs to treat, delay, or prevent Alzheimer's and other age-related neurodegenerative diseases. In this 1-day conference, experts will present major recent advances in aging biology that represent important opportunities for drug discovery for Alzheimer's and other age-related neurodegenerative diseases. The first half of the day will focus on the basic biology of aging-related pathways, with one session on major circuits and a second session on novel targets and pathways. The second half of the day will focus on drug development programs for neurodegenerative disease based on targets identified from aging biology, including recent scientific advances in the science of autophagy, mitochondrial health, inflammation, and protein homeostasis.
*Reception to follow.
For more information on the program, venue or to register please visit our Conference Website